Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
41
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Senseonics Holdings
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Dependence On One Sensor Will Intensify Risks Yet Improve Outlook
Key Takeaways Heavy reliance on a single implantable sensor platform exposes the company to risks from evolving technology and potential disruption by non-invasive alternatives. Regulatory pressures and high operating expenses may constrain margin expansion and delay the achievement of sustained profitability and positive cash flow.
View narrative
US$1.00
FV
52.7% undervalued
intrinsic discount
44.76%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Fulgent Genetics
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Regulatory Costs And Fierce Competition Will Choke Genomic Testing
Key Takeaways Heightened regulatory, privacy, and payer pressures threaten revenue growth, margin stability, and market size, potentially limiting the company's profitability and future expansion. Heavy spending on development and expansion efforts may not yield proportional returns due to fierce competition, rapid technological change, and ongoing industry commoditization.
View narrative
US$21.00
FV
1.2% overvalued
intrinsic discount
10.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Ouster
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Lidar Commoditization And Regulatory Hurdles Will Damage Prospects
Key Takeaways Competitive pressures and technological shifts threaten profitability and market share, while slower-than-expected adoption in key industries may hinder growth. Heavy dependence on major contracts and ongoing supply chain disruptions expose the company to heightened revenue and cost volatility.
View narrative
US$11.00
FV
215.6% overvalued
intrinsic discount
37.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Ranpak Holdings
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Tariff Hikes Will Hinder Packaging Operations But Automation Will Emerge
Key Takeaways Demand for recyclable packaging is rising, but advanced sustainable alternatives and large buyers threaten Ranpak's growth and pricing power. Automation and innovation investments may drive diversification, yet reliance on major customers and fixed costs create revenue and earnings volatility risks.
View narrative
US$5.00
FV
15.2% undervalued
intrinsic discount
8.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
DNA
Ginkgo Bioworks Holdings
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Intensifying Competition And Regulatory Burdens Will Hurt Synthetic Biology Revenue
Key Takeaways Reliance on project-based contracts and biosecurity funding creates revenue instability, while persistent negative cash flow limits the ability to scale and invest in growth. Intensifying competition, regulatory scrutiny, and public mistrust threaten market share and revenue realization as synthetic biology becomes more widely adopted.
View narrative
US$6.00
FV
119.7% overvalued
intrinsic discount
-7.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
ASOS
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
SHEIN Competition Will Choke Margins With Slight Efficiencies Emerging
Key Takeaways Rising sustainability expectations, inflation, and stiff competition threaten ASOS's revenue growth, profitability, and brand reputation. Ongoing challenges in inventory, returns, and regulatory compliance exert persistent pressure on margins and future earnings.
View narrative
UK£2.20
FV
39.8% overvalued
intrinsic discount
-1.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Navitas Semiconductor
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Overvalued Outlook Will Crumble As AI Demand Falters
Key Takeaways Increasing reliance on high-margin markets and emerging applications raises vulnerability to customer concentration and market shifts. Industry commoditization, trade tensions, and heavy R&D investment threaten profitability and may prolong negative free cash flow.
View narrative
US$4.40
FV
57.3% overvalued
intrinsic discount
1.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Definitive Healthcare
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Rising HIPAA Compliance And Cyber Threats Will Diminish Value
Key Takeaways Tightening data privacy rules, industry consolidation, and security concerns will shrink market opportunities and diminish revenue growth, margins, and pricing leverage. Increased competition from open-source AI tools and restricted customer IT budgets will accelerate commoditization, weaken earnings, and limit future top-line expansion.
View narrative
US$3.00
FV
29.0% overvalued
intrinsic discount
-4.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Stitch Fix
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Falling Active Customers And Tariffs Will Erode Profitability
Key Takeaways Sustained declines in active clients and shifts toward new apparel models threaten future revenue growth and challenge the viability of Stitch Fix's core business. Rising costs, stronger competition, and economic pressures are compressing margins and jeopardizing ongoing profitability.
View narrative
US$3.00
FV
64.3% overvalued
intrinsic discount
-0.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies